On April 14, 2022, The Marker Group, Inc. filed official notice of a September 2021 data breach that compromised the names, dates of birth, Social Security numbers and protected health information of ...

An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer We assessed cancer-related molecular marker test ...

HOUSTON, Feb. 11, 2020 /PRNewswire/ -- Marker Therapeutics, Inc. (NASDAQ: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based ...

Thank you for your recent editorial describing an effort, initiated by the International Funders Forum, to develop a robust marker paper procedure that will provide the user community with important ...

This practical review on the use of serum markers and circulating tumor cells (CTCs) focuses on the role of these assays in the management of patients with breast cancer and contains important ...